Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis
Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Ryoji Koshiba, Yuki Hirata, Kazuhiro Ota, Takako Miyazaki, Shiro Nakamura, Kayoko Sakagami, Shoko Arimitsu, Hiroaki Ito, Hiroki Nishikawa · 2024
Read Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis by Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Ryoji Koshiba, Yuki Hirata, Kazuhiro Ota, Takako Miyazaki, Shiro Nakamura, Kayoko Sakagami, Shoko Arimitsu, Hiroaki Ito, Hiroki Nishikawa (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10672609.txt.
Description
Yoshihiro Tatsumi and co-authors test, in a 2023 study, which blood and stool markers best track the ups and downs of ulcerative colitis. This gut disease flares and settles, and doctors need cheap markers that move with it between scope exams. A newer blood marker raised a special question about a common drug class.
Forty-eight patients gave samples twice, at least eight weeks apart. Changes in six markers were set against changes in a standard symptom score. Two markers, LRG and IL-6, moved most tightly with the score. The study also checked whether anti-TNF drugs blunt the new marker's response, a concern for patients on that therapy.
Catalog record
| CREATOR | Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Ryoji Koshiba, Yuki Hirata, Kazuhiro Ota, Takako Miyazaki, Shiro Nakamura, Kayoko Sakagami, Shoko Arimitsu, Hiroaki Ito, Hiroki Nishikawa |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |